Oral Manifestation in Patients With SARS-CoV2 Infection.

Status Completed

Clinical Trial Summary

The oral cavity is particularly susceptible to viral infection with several viruses such as herpes simplex virus, cytomegalovirus and Zika virus because of its structures, especially salivary glands and soft tissues Moreover, oral mucosa can be affected by secondary pathological process of a bacterial or fungal nature due to viral immunosuppression. The oral cavity could be considered a "biological barometer" of both viral infection and viral immunosuppression advancement .

Clinical Trial Description

The SARS-Cov2 virus was identified in china at the end of 2019 and spread worldwide causing a global pandemic. Current research showed that SARS-Cov2 virus invades human cells via the receptor angiotensin-converting enzyme 2 (ACE2) through scRNA-seq data analyses. The study identified the organs that are at risk and are vulnerable to SARS-CoV-2 infection. Therefore, cells with ACE2 receptor distribution may become host cells for the virus and cause inflammatory response in related organs and tissues, such as the tongue mucosa and salivary glands. These results suggest that oral mucosa could be a target of SARS-CoV-2 infection . Although many authors reported the presence of oral lesion associated with SARS-CoV2 infection, the prevalence of the oral manifestation and the range of oral manifestation are still unknown. Further studies are necessary to better understanding of the symptoms of the SARS-CoV2 virus in order to faster detection. A multidisciplinary team following the patients could be the key in treatment of the infection and faster recovery. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04821986
Study type	Observational
Source	Fayoum University
Contact
Status	Completed
Phase
Start date	April 1, 2021
Completion date	October 15, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04961541` - Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine	Phase 1/Phase 2
Active, not recruiting	`NCT04546776` - COVID-19 Persistence in Stool
Terminated	`NCT04542993` - Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy	Phase 2
Completed	`NCT05065827` - Lung Ultrasound Findings in Patients With COVID-19 in a UK ED
Completed	`NCT04542915` - COVID-19-Related Health and Practices Among Dental Hygienists
Recruiting	`NCT04615052` - Home-based Exercise in COVID-19 Survivors	N/A
Enrolling by invitation	`NCT04659486` - Adolescents With COVID-19/MIS-C at HCFMUSP	N/A
Recruiting	`NCT04885452` - Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort.
Completed	`NCT05063812` - Performance of a Remote Monitoring Program for Patients Diagnosed With COVID-19
Completed	`NCT04516928` - Study of SARS-CoV2 Virus (COVID-19) Seroprevalence Among Lyon-Bron Military Health Schools Personnel
Completed	`NCT04530357` - Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 Vaccine	Phase 1/Phase 2
Recruiting	`NCT04565782` - Corona Virus Infection Among Liver Transplant Recipients
Completed	`NCT04733625` - The Effect of Vitamin D Therapy on Morbidity and Moratlity in Patients With SARS-CoV 2 Infection	N/A
Completed	`NCT04550390` - Study of the Analytical Performance of Different Salivary Self-collection Methods for the Detection of COVID-19
Active, not recruiting	`NCT04517136` - Impact of Perceived Control on Operational Strain: a Study of COVID-19 Pandemic Caregivers and Military Personnel on Operational Missions
Recruiting	`NCT04476680` - Influence of Military Preventive Policy for reCruit Training on COVID-19 Seroconversion	N/A
Completed	`NCT04839913` - Seroprevalence of SARS-CoV-2 in Unselected Surgical Patients: an Unicentric, Regional Study
Completed	`NCT04514874` - Assessment of the Prevalence and the Impact of the COVID-19 Epidemic in the French Flight Crew in 2020
Terminated	`NCT04606563` - Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?	Phase 3
Completed	`NCT05234359` - The CHILD Cohort COVID-19 Add-On Study